Quantitative DNA alterations during 5-azacytidine-induced differential modulation of benzo(a)pyrene carcinogenesis in hamster bronchi.
Sustained release implants (SRI) containing 10% benzo(a)pyrene (BP) were placed endobronchially into outbred and syngeneic (F1D) hamsters. Randomly selected OB and F1D hamsters also received 5-azacytidine (AZC), 5 mg/kg i.p., twice weekly until death (AZC-CONT); two more groups of F1D hamsters were given the same AZC dose either for the first 75 days of SRI implantation (AZC-EARLY) or from 80 days after SRI placement until death (AZC-LATE). OB Hamsters were sacrificed at regular intervals from 62 to 189 days of SRI exposure. F1D Hamsters were sacrificed in groups after 120, 150, 180, and 220 days of SRI exposure. The bronchial mucosa at the SRI site was examined cytologically and histologically, as were the tumors that developed. Mean quantitative total cellular DNA values (QDNA) were measured by image analysis. For both varieties of hamster given AZC, QDNA values were higher in early carcinogenesis (CG) and lower in the late stage of CG than in hamsters that did not get AZC (P less than 0.001). QDNA values were lower in epidermoid than in non-epidermoid cancers (P less than 0.001); for both types of cancer, QDNA was lower in AZC-treated hamsters (P less than 0.01). Cancers induced under the influence of AZC included more epidermoid cancers (P less than 0.01) and were of a higher degree of differentiation (P less than 0.01) than those induced by BP alone, especially when AZC was given early in CG. There was no consistent relationship between QDNA and degree of differentiation in tumors. These differential effects of AZC given early during CG suggest that 1) for epidermoid bronchial CG, some of the molecular alterations involved in hyperploidy and in differentiation occur early in the sequential progression of carcinogenesis; and 2) for both epidermoid and non-epidermoid bronchial CG, the necessary changes must occur in a fixed sequence instead of as random events, until all needed changes have occurred.
Hammond
W G
WG
Department of Thoracic Surgery, City of Hope National Medical Center, Duarte, CA 91010.
Yellin
A
A
Gabriel
A
A
Azumi
N
N
Hill
L R
LR
Teplitz
R L
RL
Benfield
J R
JR
D000818:Animals; D001374:Azacitidine / Q000494:pharmacology*; D001564:Benzo(a)pyrene / Q000633:toxicity*; D001980:Bronchi / Q000187:drug effects / Q000473:pathology; D006224:Cricetinae; D004247:DNA / Q000187:drug effects*; D004273:DNA, Neoplasm / Q000187:drug effects*; D004343:Drug Implants; D008175:Lung Neoplasms / Q000139:chemically induced / Q000473:pathology*; D008647:Mesocricetus; D011003:Ploidies
D004273:DNA, Neoplasm; D004343:Drug Implants; D001564:Benzo(a)pyrene; D004247:DNA; D001374:Azacitidine